Miranda R Andrus

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Postmenopausal Women

Top Venues

Expert opinion on pharmacotherapy

The Annals of pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Megan Z Roberts, Miranda R Andrus
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause. Expert opinion on pharmacotherapy 25 (9) (2024)
Megan Z Roberts, Miranda R Andrus
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause. Expert opinion on pharmacotherapy 25 (9) (2024)
Megan Z Roberts, Miranda R Andrus
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause. Expert opinion on pharmacotherapy (2024)
Miranda R Andrus
E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Continues: An Opportunity for Pharmacist Intervention. The Annals of pharmacotherapy (2023)